Arrowhead Research Corporation (ARWR) and Axolabs GmbH Enter into Strategic Alliance and Master Services Agreement for RNAi Therapeutics

3/5/2012 6:44:01 AM

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation, a nanomedicine company with development programs in RNAi therapeutics and obesity, and Axolabs GmbH, a custom research organization offering preclinical solutions and consultancy in the field of oligonucleotide therapeutics, today announced that they have entered into a Strategic Alliance and Master Services Agreement.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Arrowhead Research Corporation

• Biotech/Pharma - Alliances